candesartan cilexetil has been researched along with Elevated Cholesterol in 3 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichikawa, N | 1 |
| Toma, N | 1 |
| Kawakita, F | 1 |
| Matsushima, S | 1 |
| Imanaka-Yoshida, K | 1 |
| Yoshida, T | 1 |
| Taki, W | 1 |
| Suzuki, HI | 1 |
| Shibouta, Y | 2 |
| Chatani, F | 1 |
| Ishimura, Y | 2 |
| Sanada, T | 1 |
| Ohta, M | 2 |
| Inada, Y | 1 |
| Nishikawa, K | 1 |
| Matsuo, T | 1 |
| Ishikawa, E | 1 |
| Imura, Y | 1 |
| Sugiyama, Y | 1 |
3 other studies available for candesartan cilexetil and Elevated Cholesterol
| Article | Year |
|---|---|
Angiotensin II type 1 receptor blockers suppress neointimal hyperplasia after stent implantation in carotid arteries of hypercholesterolemic rabbits.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Carotid Artery | 2015 |
TCV-116 inhibits renal interstitial and glomerular injury in glomerulosclerotic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl | 1996 |
Renal protective effect of candesartan cilexetil in spontaneously hypercholesterolemic rats.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Be | 2002 |